Mira Pharmaceuticals Inc (MIRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 2,438 | 2,082 | 1,731 | 1,768 | 3,056 |
| Operating Income | -2,438 | -2,082 | -1,731 | -1,768 | -3,056 |
| Other Income | 38 | 38 | 39 | 50 | -2,731 |
| Pre-tax Income | -2,400 | -2,044 | -1,691 | -1,718 | -5,787 |
| Net Income Continuous | -2,400 | -2,044 | -1,691 | -1,718 | -5,787 |
| Net Income | $-2,400 | $-2,044 | $-1,691 | $-1,718 | $-5,787 |
| EPS Basic Total Ops | -0.11 | -0.14 | -0.11 | -0.15 | -0.39 |
| EPS Basic Continuous Ops | -0.14 | -0.14 | -0.11 | -0.12 | -0.43 |
| EPS Diluted Total Ops | -0.11 | -0.14 | -0.11 | -0.15 | -0.39 |
| EPS Diluted Continuous Ops | -0.14 | -0.14 | -0.11 | -0.12 | -0.43 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.14 | -0.11 | N/A | N/A |
| EBITDA(a) | $-2,438 | $-2,082 | $-1,731 | $-1,768 | $-3,056 |